Zurueck zur Suche

Reporte zur Charge UT7701MA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 2 NH 1 OH 1 VT 1 MN 1 CO 1 NJ 1 WI 1

VAERS 2481748

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7701MA

schwer
Staat
NH
Alter
19,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Electrocardiogram Hyperhidrosis Loss of consciousness Pallor

Symptomtext

Patient was walking down the hall after her vaccine and felt dizzy/lightheaded. Patient stated the thought of needles/blood does this to her and has happened before. Patient was assisted to a chair where she lost consciousness briefly and became very pale and diaphoretic. Patient regained consciousness and was evaluated by EMS prior to returning to work.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
BP/Pulse/ EKG
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
Latex
Vorherige Impfungen
Fainting

VAERS 2490096

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7701MA

moderat
Staat
PA
Alter
32,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chiropractic Exposure during pregnancy Massage Migraine Nausea Neck pain Sleep disorder

Symptomtext

Currently 36 weeks pregnant due November 23, 2022. Got the worst migraine of my life starting around 1130pm the night of vaccine which woke me from sleeping and came with neck pain and nausea. Attempted Tylenol, Reglan, sleep, ice, hydration, massage, chiropractor, caffeine, all with minimal relief

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
asthma, hypothyroidism
Andere Medikamente
Prenatal vitamins
Allergien
Keflex, Latex
Vorherige Impfungen
-

VAERS 2464932

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7701ma

moderat
Staat
OH
Alter
9,0
Geschlecht
M
Eingang
29.09.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure increased Feeling hot Headache Heart rate increased Hypertension Nausea

Symptomtext

started to feel nauseous and hot. he had a headache later and high blood pressure and heart rate

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypertension
Hospital-Tage
-
Labordaten
blood pressure test 9/29/22
Aktuelle Erkrankungen
unknown
Vorgeschichte
nka
Andere Medikamente
nka
Allergien
nka
Vorherige Impfungen
-

VAERS 2542680

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7701MA

mild
Staat
-
Alter
26,0
Geschlecht
M
Eingang
24.12.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Nausea

Symptomtext

dizziness; lightheaded; nausea; nauseated; Initial information received on 19-Dec-2022 regarding an non-serious case received from via consumer/non-hcp. This case involves a 26 years old male patient who was diagnosed with dizziness; lightheaded and nausea; nauseated after receiving influenza quadrival a-b high dose hv vaccine [Fluzone High-Dose Quadrivalent] and vaccines covid-19 vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Nov-2022, the patient received a dose suspect influenza quadrival a-b high dose hv vaccine at dose 1 (batch number: UT7701MA) (strength, frequency, formulation, expiry date: unknown) via intramuscular route in the right arm for Influenza immunization. On 21-Nov-2022, the patient received suspect covid-19 vaccine produced by unknown manufacturer at dose 2 in injection form (batch number: 4302MF023) (strength, expiry date: unknown) via intramuscular route in the left arm for COVID-19 immunisation On 21-NOV-2022 the patient diagnosed with a non-serious events of dizziness; lightheaded (dizziness), nausea; nauseated (nausea) (same day latency) following the administration of influenza quadrival a-b high dose hv vaccine and following the administration of covid-19 vaccine. Action taken was not applicable for both suspects. It was not reported if the patient received a corrective treatment for both the events. At time of reporting, the outcome was Unknown for both events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2513024

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7701MA

mild
Staat
VT
Alter
26,0
Geschlecht
M
Eingang
21.11.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Nausea

Symptomtext

After shot was administered patient felt lightheaded and nauseated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2506039

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7701MA

mild
Staat
MN
Alter
31,0
Geschlecht
U
Eingang
11.11.2022
Impfdatum
08.11.2022
Beginn
09.11.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Injection site pain

Symptomtext

Patient reported the next day he had numbness in his arms like he had been laying on them. The initial site does not hurt when hurts when patient makes a fist. Patient advised to take rotate tylenol and ibuprofen, warm/cold compresses and to f/u in clinic if symptoms do not improve or worsen Patient communicated this information through patient portal

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
sinusitis
Vorgeschichte
type 2 DM, depression, anxiety, migraines, asthma, hirsutism, gender dysphoria
Andere Medikamente
Depotestosterone, hydroxyzine, lipitor, duo nebs, albuterol inhaler, naproxen, flexeril, sudafed, flonase, valtrex, iron, zofran, testosterone cypionate, motrin, imodium, vitamin d3, benadryl, prilosec, tylenol
Allergien
Morphine, decardron, doxycycline, metformin
Vorherige Impfungen
-

VAERS 2595663

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7701MA

gering
Staat
PA
Alter
0,3
Geschlecht
F
Eingang
13.03.2023
Impfdatum
13.03.2023
Beginn
13.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administration error Product label on wrong product Wrong product administered

Symptomtext

Influenza vaccine listed above was stored in a box labeled prevnar in error. Office protocol to verify vaccines by 2 staff members was followed. However, neither staff identified that the syringe was influenza and not prevnar. Staff then administered the vial 0.5ml IM influenza in error, while intending to administer prevnar. This was injected into the right thigh at 14:38. Parent was immediately notified of the error. No adverse reaction to the influenza vaccine was observed while the patient remained in our office.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2513989

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7701MA

gering
Staat
CO
Alter
56,0
Geschlecht
F
Eingang
22.11.2022
Impfdatum
12.10.2022
Beginn
21.11.2022
Tage bis Beginn
40,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient receiced Fluzone Quad 2022 Lot number: UT7695NA on 10/12/2022 . She forgot she had already received influenza vaccine for the season and had another Fluzone Quad 2022 vaccine administered on 11/21/2022 Lot number UT7701MA. No adverse reaction noted at this time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 2495935

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7701MA

gering
Staat
NJ
Alter
72,0
Geschlecht
F
Eingang
02.11.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Wrong product administered

Symptomtext

72 years old administered fluzone qiv instead of the fluzone hd qiv with no reported adverse event; Initial information received on 25-Oct-2022 regarding an unsolicited valid non-serious case received via Nurse. Agency number: 01337732. This case involves a 72-year-old female patient to whom INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] was administered instead of the fluzone hd qiv with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. No concomitant medications were given. On 25-Oct-2022, the 72-year-old patient received suspect fluzone qiv at dose 0.5ml once (lot: UT7701MA, expiry date: 30-Jun-2023) via intramuscular route in the right deltoid for immunization instead of the fluzone hd qiv with no reported adverse event (wrong product administered) at same day latency. It was reported that "Nurse called stating a patient received the FLUZONE QIV instead of the FLUZONE HD QIV. Caller inquired if the patient needs to be revaccinated or how to proceed with ensuring the patient is fully vaccinated. The nurse who gave it was very upset and when the nurse came back from lunch put her on the phone. Says the patient just walked in and asked for a flu shot because she had been in the office the day before but went home and forgot to get it. Physician didn't order a specific vaccine and discussed with the nurse the patient is age appropriate for Fluzone Quadrivalent, but she says her company is making a hard push that anyone over 64 years old they should give them the Fluzone High Dose Quadrivalent. The company is pushing to give anyone over 64 should be getting the Fluzone High Dose Quadrivalent." Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2462858

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UT7701MA

gering
Staat
WI
Alter
63,0
Geschlecht
U
Eingang
28.09.2022
Impfdatum
17.09.2022
Beginn
17.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Needle issue No adverse event Underdose

Symptomtext

a lot of the medication was leaked out from the sides of the needle resulting in an under dose,as an occupational/accidental exposure with no reported adverse event; Initial information (received on 19-Sep-2022 processed as non-case) with additional information 19-Sep-2022 regarding an unsolicited valid non-serious case received from a pharmacist. Agency number: 01284280. This case involves a 63-year-old and unknown gender patient who experienced a lot of the medication was leaked out from the sides of the needle resulting in an under dose, as an occupational/accidental exposure with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B INTRADERMAL VACCINE [FLUZONE]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Sep-2022, the patient received suspect FLUZONE QIV NP at dose 0.5ml once via intramuscular route in the left deltoid (lot: UT7701MA, expiry date: 30-Aug-2022) for Influenza immunization. The patient used the product first time. On 17-SEP-2022, the patient developed a non-serious a lot of the medication was leaked out from the sides of the needle resulting in an under dose, as an occupational/accidental exposure with no reported adverse event (accidental exposure to product) at same day latency. Pharmacist calling to inquire about a FLUZONE QIV NP, a patient was receiving vaccination on 17Sep2022, the needle they used was damaged and a lot of the medication was leaked out from the sides of the needle resulting in an under dose. They are seeking guidance on how to handle this situation. This situation is reported as an occupational/accidental exposure. Action taken: Not applicable. The patient was still using product. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-